ORCHID PHARMA
|
The Current P/E Ratio of ORCHID PHARMA is 165.72.
| Share Price | ₹567.5 | Apr 15,2026 |
| Market Cap | ₹2,877.2 Cr | |
| Earnings-TTM | ₹17.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 165.72x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ORCHID PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,877.2 Cr] as on Apr 15,2026
(/) Earnings [ ₹17.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 165.72x ]
Thus, for ORCHID PHARMA , the investors are currently willing to pay 165.72 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ORCHID PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ORCHID PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ORCHID PHARMA
PE Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.19x.
- ORCHID PHARMA 's operated at median p/e ratio of 33.87x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2024 at 57.52x.
- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does ORCHID PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ORCHID PHARMA | 17.36 | 165.72 | 2,877.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.00 | 407,083.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 66.14 | 163,971.0 |
| CIPLA LTD | 4,544.70 | 21.80 | 99,086.7 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 61.91 | 140,660.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.46 | 101,686.0 |
| MANKIND PHARMA LTD | 1,796.65 | 48.77 | 87,624.9 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 19.09 | 94,183.5 |
| LUPIN LTD | 4,669.18 | 22.90 | 106,943.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 22.74 | 79,889.3 |
| ABBOTT INDIA LTD | 1,524.13 | 36.21 | 55,184.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ORCHID PHARMA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.46x |
| Max industry PE | 165.72x |
| Median industry PE | 36.21x |
| Average industry PE | 47.34x |
You may also like the below Video Courses